Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03733990
Title A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Faron Pharmaceuticals Ltd
Indications

hepatocellular carcinoma

colorectal adenocarcinoma

pancreatic ductal adenocarcinoma

estrogen-receptor positive breast cancer

thyroid gland anaplastic carcinoma

gastric adenocarcinoma

ovarian cancer

skin melanoma

uveal melanoma

esophagus adenocarcinoma

cholangiocarcinoma

gastroesophageal junction adenocarcinoma

ovary serous adenocarcinoma

gallbladder cancer

Therapies

FP-1305

Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP


No variant requirements are available.